Critical Questions in Choosing EGFR-Targeted Therapies for NSCLC - Episode 4
Treatment Strategies to Manage AEs in EGFRm NSCLC
Panelists discuss how medical professionals have learned that proactive monitoring, early intervention, and patient-centered strategies are key to managing adverse events (AEs) in up-front combination therapy. Optimizing dosing, supportive care, and multidisciplinary coordination help maintain quality of life while ensuring treatment efficacy.
Video content above is prompted by the following:
When using combination therapy up front, what have been your key learnings about managing AEs and maintaining quality of life?
Related Content:
